Table 3.
Positive-NSN rates in multivariate analysis for patients with completion ALND and radiotherapy.
| Odds ratio | 95% CI | P value | |
|---|---|---|---|
| AC | |||
| No | 1 | ||
| AC after ALND | 2.99 | 1.70–5.24 | <0.0001 |
| AC before ALND | 1.51 | 0.77–2.98 | 0.2318 |
| Tumor size | |||
| ≤10 | 1 | ||
| 10–30 | 1.92 | 0.86–4.32 | 0.1124 |
| >30 | 1.26 | 0.46–3.43 | 0.6547 |
| LVI | |||
| No | 1 | ||
| Yes | 0.80 | 0.52–1.23 | 0.2992 |
| Grade SBR | |||
| 1 | 1 | ||
| 2 | 1.21 | 0.66–2.19 | 0.5376 |
| 3 | 0.89 | 0.45–1.79 | 0.7480 |
| Nb positive SN | |||
| ≤2 | 1 | ||
| >2 | 3.45 | 1.21–9.85 | 0.0209 |
| Extracapsular extension | |||
| No | 1 | ||
| Yes | 1.21 | 0.75–1.94 | 0.4346 |
| SN status | |||
| ITC | 1 | ||
| Micro-metastases | 1.62 | 0.35–7.59 | 0.5370 |
| Macro-metastases | 3.70 | 0.84–6.33 | 0.0842 |
LVI lympo-vacular invasion, SN sentinel node, AC adjuvant chemotherapy.
Bold entries indicate statistical significant differences.